INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Invivo Therapeutics Holdings Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2023.
  • Invivo Therapeutics Holdings Corp. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $643K, a 38.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $643K -$396K -38.1% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $744K -$391K -34.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $844K -$385K -31.3% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 $942K +$109K +13.1% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.04M +$120K +13.1% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.14M +$282K +33.1% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.23M +$301K +32.4% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $833K -$167K -16.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $919K -$153K -14.3% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $853K -$289K -25.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $928K -$283K -23.4% Dec 31, 2020 10-K 2022-03-07
Q3 2020 $1M -$278K -21.8% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $1.07M -$273K -20.3% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $1.14M -$268K -19% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $1.21M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $1.28M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.35M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $1.41M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.